CARVER KYLE (Chief Financial Officer) sold 23.4% of their position (18.18K shares) of EVOMMUNE, INC. on the open market
Open‑market sale worth $415.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/1/2026ACC: 0001757072-26-000005
Officer· Chief Financial Officer
Since Nov 2025
-18.18K
Net shares
Net seller
$415.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 33.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$2.99
Trade value
$44.85K
% of position
24.0%
5/28/2026
62.51K→77.51K
Common Stock
Direct
Shares
−18.18K
Price / share
$22.84
Trade value
$415.12K
% of position
23.4%
5/28/2026
77.51K→59.34K
Total
Net shares
−3.17K
Net value
-$370.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/28/2026 | M · Option Exercise | +15K | $2.99 | $44.85K | 24.0% | 62.51K | 77.51K |
| Common Stock Direct | 5/28/2026 | S · Sale | −18.18K | $22.84 | $415.12K | 23.4% | 77.51K | 59.34K |
| Total | −3.17K | -$370.27K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
2.99
Held after
96.73K
Exercisable
—
5/28/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock15K shares | 5/28/2026 | M · Option Exercise | −15K | 2.99 | — | 96.73K |